i am on semaglutide and not losing weight Why Semaglutide? Why Am I Not Losing

Conclusion GLP-1 RAs may significantly lower the combined risk of mortality and hospitalization in patients with HFpEF

Objective: To evaluate the efficacy and safety of semaglutide combined with metformin in treating type 2 diabetes mellitus (T2DM) patients who are overweight or obese

If reconstituted with 5mL of sterile water , the following dosing conversions apply: 25mg = 0.25mL (25 units) 50mg = 0.50mL (50 units) 100mg = 1.00mL (100 units) Missed Dose: If a dose is missed, administer as soon as possible unless it is close to the time of the next scheduled dose

After propensity-score matching, GLP-1 exposure was linked to nearly 30% lower odds of breast cancer, but the authors stress that randomized trials are needed before these drugs can be considered for prevention.

The molecular mechanisms of the neuroprotective effects of GLP-1 RA in diabetes-related degenerative diseases, including AD and PD, and their potential effects.

Several new uses have been found for the drugs